Mounjaro becomes India’s top-selling drug as patients shift to GLP-1 injections

Mounjaro becomes India's top-selling drug, with ₹1,256 crore in sales as patients prefer injectable GLP-1 treatments over oral options.

Raccontata dathehindubusinessline.com